WPI 3155 Pill - white capsule/oblong
Pill with imprint WPI 3155 is White, Capsule/Oblong and has been identified as Modafinil 200 mg. It is supplied by Watson Laboratories, Inc.
Modafinil is used in the treatment of Shift Work Sleep Disorder; Obstructive Sleep Apnea/Hypopnea Syndrome; Narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 200 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3155
Modafinil
- Imprint
- WPI 3155
- Strength
- 200 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
-
lactose monohydrate,
corn starch,
crospovidone,
croscarmellose sodium,
silicon dioxide,
magnesium stearate,
magnesium silicate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3500 (Discontinued) | Watson Pharmaceuticals, Inc. |
| 42291-0600 (Discontinued) | AvKare, Inc. |
| 00904-6424 (Discontinued) | Major Pharmaceuticals |
More about modafinil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (515)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
